Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone

• 主要な著者: Wenqian Wang (著者), Jian Ge (著者), Honghao Ma (著者), Hongyun Lian (著者), Lei Cui (著者), Yunze Zhao (著者), Zhigang Li (著者), Tianyou Wang (著者), Rui Zhang (著者)
• フォーマット: 図書
• 出版事項: BMC, 2024-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background The patients with multisystem and risk organ involvement Langerhans cell histiocytosis (MS-RO + LCH) have poor prognosis. The patients with MS-LCH who failed front-line therapy have a high mortality rate and the standard salvage treatment has not been established. The combination...